logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Ovation Science (CSE OVAT)

Ovation Science Inc. Announces Private Placement

May 1, 2020

Aleafia Health Inc. (TSX ALEF)

Aleafia Health to Appoint Two New Directors

May 1, 2020

Healthcare Roundup – AstraZeneca teams up with Oxford U. on COVID-19 vaccine, Molina to buy Magellan

May 1, 2020

Life Science

三叶草生物获350万美元资金,用作新冠病毒疫苗开发

Clover Bio Forms $3.5 Million Collaboration to Test COVID-19 Vaccine

Apr 30, 2020

Life Science

医疗保健精选——吉利德科学2020年第一财季收益预览,FDA批准葛兰素史克Zejula的扩展适应症

Healthcare Roundup – Gilead Sciences Q1 2020 Earnings Preview, FDA OKs expanded use of Glaxo’s Zejula 

Apr 30, 2020

Life Science

无锡国际生命科学创新园

Global Innovative Firms Land at I·Campus to Co-Explore Life Sciences

Apr 29, 2020

Life Science

Avalon GloboCare Partners with HydroPeptide, a Leader in Epigenetics Skin Care, to Accelerate Regenerative ACTEX™ Product Development and Commercialization

Apr 28, 2020

Life Science

GTEC Cannabis Co Reports Record Revenue for the First Quarter of Fiscal 2020

Apr 28, 2020

Life Science

Healthcare Roundup —— Sorrento Therapeutics in deal for up to $250M, Moderna submits IND application for Phase 2 COVID-19 study

Apr 27, 2020

Life Science

Aleafia Health Inc. (TSX ALEF)

Aleafia Health Inc. Provides Corporate Update

Apr 27, 2020

Life Science

中国原创!绿谷阿尔兹海默症新药GV-971获批在美国展开临床试验

Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s International, Phase III Clinical Study

Apr 27, 2020

Life Science

华领医药宣布Dorzagliatin与恩格列净(一种SGLT-2抑制剂)联合用药临床研究的成功结果

Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)

Apr 27, 2020

Life Science

DIAGNOS Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program

Apr 27, 2020

Life Science

医疗保健精选——借力疫苗合作伙伴赛诺菲,Translate Bio股价上涨21%;吉利德瑞德西韦试验提前出结果

Healthcare Roundup – Translate Bio jumps 21% on bullish comments from vaccine partner Sanofi, Gilead’s remdesivir trial ahead of schedule

Apr 24, 2020

Life Science

康方生物

AkesoBio Completes $335 Million Hong Kong IPO; Climbs 50% on First Trading Day

Apr 24, 2020

Life Science

豪森药业 NiKang

Hansoh Pharma and NiKang Therapeutics Enter into a Development and Commercialization Partnership for a Novel Treatment for Anti-Viral Diseases in China

Apr 24, 2020

Life Science

医疗保健综述——欧洲监管机构批准Mylan/Upjohn合并,吉利德瑞德昔韦试验失败,BioCryst股价下跌

Healthcare Roundup – European regulators on board with Mylan/Upjohn tie-up, BioCryst feels Gilead’s remdesivir pain

Apr 23, 2020

Life Science

医疗保健精选——FDA批准Immunomedics抗体-药物偶联物治疗乳腺癌,辉瑞和BioNTech展开COVID-19疫苗研究

Healthcare Roundup – FDA OKs Immunomedics antibody-drug conjugate for breast cancer, Pfizer and BioNTech on go with COVID-19 vaccine study

Apr 23, 2020

Life Science

  • ‹‹ Previous
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada